PCI Synthesis Overview

  • Founded
  • 1995

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 150

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 1

PCI Synthesis General Information

Description

Manufacturer of small molecule drug substance and other specialty chemical products. The company offers a wide range of services, including process research and early-stage development as well as commercial production of new chemical entities, generic active pharmaceutical ingredients and other specialty chemical products, providing pharmaceutical and medical device industries with drugs delivery at a competitive price.

Contact Information

Formerly Known As
Polycarbon Industries Inc., Polycarbon Industries Incorporated
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Multi-line Chemicals
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 9 Opportunity Way
  • Newburyport, MA 01950
  • United States
+1 (978) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PCI Synthesis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PCI Synthesis‘s full profile, request access.

Request a free trial

PCI Synthesis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of small molecule drug substance and other specialty chemical products. The company offers a wide range of
Multi-line Chemicals
Newburyport, MA
150 As of 2018
000000000000

00000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
000000000000000
Sao Paulo, Brazil

000000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
000000000000000
Plankstadt, Germany
0000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PCI Synthesis Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bayer (Brazil) Corporation Sao Paulo, Brazil
000000000000 Private Equity-Backed Plankstadt, Germany 0000 000000000000
00000000 00000000 Corporate Backed or Acquired College Station, TX 0000 0000000000
000000 (0000000000 Formerly VC-backed San Diego, CA 00 00.00 000000&0 00.00
000000 Private Equity-Backed Clearwater, FL 000 0000 000000 - 000
To view PCI Synthesis’s complete competitors history, request access »

PCI Synthesis Patents

PCI Synthesis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3728178-A4 Synthesis of azelaic acid Inactive 22-Dec-2017 000000000 0
EP-3728178-A1 Synthesis of azelaic acid Inactive 22-Dec-2017 000000000
US-10358408-B2 Synthesis of azelaic acid Active 22-Dec-2017 000000000 00
US-20190194115-A1 Synthesis of azelaic acid Active 22-Dec-2017 000000000
CA-3086530-A1 Synthesis of azelaic acid Pending 22-Dec-2017 C07C51/38
To view PCI Synthesis’s complete patent history, request access »

PCI Synthesis Executive Team (2)

Name Title Board Seat Contact Info
Edward Price Founder, President & Chief Executive Officer
Paul Sulloway Chief Financial Officer, Finance & Chief Operating Officer, Operations
To view PCI Synthesis’s complete executive team members history, request access »

PCI Synthesis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PCI Synthesis Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00 23-Aug-2005 0000000000 Industrial Chemicals 000000 00
To view PCI Synthesis’s complete acquisitions history, request access »